These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8474351)
1. Generation and analysis of vaccinia virus recombinants. Mazzara GP; Destree A; Mahr A Methods Enzymol; 1993; 217():557-81. PubMed ID: 8474351 [No Abstract] [Full Text] [Related]
2. Molecular approaches to AIDS vaccine development using baculovirus expression vectors. Kang CY Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523 [No Abstract] [Full Text] [Related]
3. Sequences in the rev-responsive element responsible for premature translational arrest in the human-immunodeficiency-virus-type-1 envelope. Ellerbrok H; Serpente N; Pancino G; Vanhée C; D'Auriol L; Sitbon M; Vaquero C Eur J Biochem; 1993 Sep; 216(2):459-67. PubMed ID: 8375384 [TBL] [Abstract][Full Text] [Related]
4. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors. Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479 [TBL] [Abstract][Full Text] [Related]
5. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses. Otteken A; Voss G; Hunsmann G Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426 [TBL] [Abstract][Full Text] [Related]
6. Sulfation of the human immunodeficiency virus envelope glycoprotein. Bernstein HB; Compans RW J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500 [TBL] [Abstract][Full Text] [Related]
7. Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus. Klaniecki J; Dykers T; Travis B; Schmitt R; Wain M; Watson A; Sridhar P; McClure J; Morein B; Ulrich JT AIDS Res Hum Retroviruses; 1991 Oct; 7(10):791-8. PubMed ID: 1742074 [TBL] [Abstract][Full Text] [Related]
8. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain. Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 gp120/160 expressing transfected cell clones to evaluate the antibody-dependent cellular cytotoxicity (ADCC) during the course of HIV-1 infection. Merzouki A; Patel P; Cassol S; O'Shaughnessy M; Gill J; Arella M J Virol Methods; 1994 Jun; 48(1):9-21. PubMed ID: 7962264 [TBL] [Abstract][Full Text] [Related]
10. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis]. Chen Y; Garcia R; Baralle FE Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506 [TBL] [Abstract][Full Text] [Related]
11. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. Earl PL; Hügin AW; Moss B J Virol; 1990 May; 64(5):2448-51. PubMed ID: 2182912 [TBL] [Abstract][Full Text] [Related]
12. Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells. Ivey-Hoyle M; Rosenberg M Mol Cell Biol; 1990 Dec; 10(12):6152-9. PubMed ID: 2123289 [TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4. Ashorn P; Berger EA; Moss B Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369 [No Abstract] [Full Text] [Related]
14. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Willey RL; Klimkait T; Frucht DM; Bonifacino JS; Martin MA Virology; 1991 Sep; 184(1):319-29. PubMed ID: 1871974 [TBL] [Abstract][Full Text] [Related]
15. In vitro infection of human placental trophoblast by wild-type vaccinia virus and recombinant virus expressing HIV envelope glycoprotein. Nørskov-Lauritsen N; Zachar V; Petersen PM; Hager H; Aboagye-Mathiesen G; Ebbesen P Res Virol; 1992; 143(5):321-8. PubMed ID: 1480824 [TBL] [Abstract][Full Text] [Related]
16. Role of HIV-1 envelope V3 loop cleavage in cell tropism. Gu R; Westervelt P; Ratner L AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475 [TBL] [Abstract][Full Text] [Related]
17. Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells. Zaides V; Yagello M; Veselovskaya T; Schmitt D; Rykova L; Fenouillet E; Gluckman JC J Gen Virol; 1994 Nov; 75 ( Pt 11)():2963-75. PubMed ID: 7964606 [TBL] [Abstract][Full Text] [Related]
18. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells. Rodriguez D; Rodriguez JR; Esteban M AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199 [TBL] [Abstract][Full Text] [Related]
19. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine. Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S73-5. PubMed ID: 7532425 [No Abstract] [Full Text] [Related]
20. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]